Matches in Wikidata for { <http://www.wikidata.org/entity/Q64149724> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q64149724 description "clinical trial" @default.
- Q64149724 description "ensayu clínicu" @default.
- Q64149724 description "klinisch onderzoek" @default.
- Q64149724 description "клінічне випробування" @default.
- Q64149724 description "կլինիկական փորձարկում" @default.
- Q64149724 name "Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)" @default.
- Q64149724 type Item @default.
- Q64149724 label "Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)" @default.
- Q64149724 prefLabel "Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)" @default.
- Q64149724 P1050 Q64149724-7E6AAE23-B154-4EFE-B173-72ECD0B6F6E3 @default.
- Q64149724 P1132 Q64149724-B80C795A-86BC-4BA6-9B5D-02FBD9F2AE3A @default.
- Q64149724 P1476 Q64149724-256E2AB3-63FF-4F69-8C19-58503D4DDDE0 @default.
- Q64149724 P17 Q64149724-1B9C5181-9606-4647-AC93-4CBE60264526 @default.
- Q64149724 P17 Q64149724-2B2B5E07-865B-4E32-8059-682C34614FA4 @default.
- Q64149724 P17 Q64149724-51378B02-5489-4FA1-9F9A-6352A630F0C0 @default.
- Q64149724 P17 Q64149724-673F1373-22DB-4EF2-AE47-738DB22F5207 @default.
- Q64149724 P17 Q64149724-BAD283E4-6039-4AD7-8E57-A5AEDFDC76A0 @default.
- Q64149724 P17 Q64149724-C18EE8E6-2E0E-4CA8-8484-A9CE710E01E4 @default.
- Q64149724 P17 Q64149724-D1E47E5D-F428-4FCC-AE21-D83106CAE7CF @default.
- Q64149724 P17 Q64149724-E08C0B90-421A-44B4-8051-07C338184589 @default.
- Q64149724 P17 Q64149724-F2B5DE92-A188-42AC-9D91-F6EA5567E05F @default.
- Q64149724 P2899 Q64149724-8344AF4A-F636-45B7-AE2C-8C3DA2C8A1C3 @default.
- Q64149724 P3098 Q64149724-050C48A8-608D-421A-8B5A-23CB0E825D7E @default.
- Q64149724 P31 Q64149724-13F3B3F1-8BC5-40DA-8042-A6FF0AADD69D @default.
- Q64149724 P4844 Q64149724-3CAD754D-8781-40CA-BD6C-42876BDC7ACD @default.
- Q64149724 P580 Q64149724-034A5105-7567-4282-AB05-1638ED48514A @default.
- Q64149724 P582 Q64149724-1A9DB759-9E06-4962-B271-73A8E73CC818 @default.
- Q64149724 P6099 Q64149724-395DC767-F94F-4438-B409-34F7024E1BF5 @default.
- Q64149724 P8363 Q64149724-EACB47A4-33D1-40F9-A22C-48C1F5F71DE4 @default.
- Q64149724 P1050 Q33525 @default.
- Q64149724 P1132 "+570" @default.
- Q64149724 P1476 "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)" @default.
- Q64149724 P17 Q142 @default.
- Q64149724 P17 Q145 @default.
- Q64149724 P17 Q20 @default.
- Q64149724 P17 Q28 @default.
- Q64149724 P17 Q29 @default.
- Q64149724 P17 Q30 @default.
- Q64149724 P17 Q38 @default.
- Q64149724 P17 Q414 @default.
- Q64149724 P17 Q801 @default.
- Q64149724 P2899 "+18" @default.
- Q64149724 P3098 "NCT03833167" @default.
- Q64149724 P31 Q30612 @default.
- Q64149724 P4844 Q13896859 @default.
- Q64149724 P580 "2019-04-01T00:00:00Z" @default.
- Q64149724 P582 "2026-04-06T00:00:00Z" @default.
- Q64149724 P6099 Q42824827 @default.
- Q64149724 P8363 Q78089383 @default.